MRI-based estimation of liver function by intravoxel incoherent motion diffusion-weighted imaging

Magnetic Resonance Imaging

Volumn 34, Issue 8, 2016, Pages 1220-1225

  Zhang, Jing ^a   Guo, Yihao ^a   Tan, Xiangliang ^a   Zheng, Zeyu ^a   He, Mengqi ^a   Xu, Jun ^a   Mei, Yingjie ^b   Zhang, Jiajun ^a   Zhao, Xixi ^a   Wang, Chunhong ^a   Feng, Yanqiu ^a   Chan, Queenie ^b   Wu, Yuankui ^a   Xu, Yikai ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Child Pugh class; DWI; Intravoxel incoherent motion; Liver function

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHILD PUGH SCORE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMAGE ANALYSIS; INTRAVOXEL INCOHERENT MOTION; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGIST; DIAGNOSTIC IMAGING; LIVER; MIDDLE AGED; MOTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84979521217     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2016.05.013     Document Type: Article

References (29)

1. [1] Seyama, Y, Kokudo, N, Assessment of liver function for safe hepatic resection. Hepatol Res 39 (2009), 107–116.
2. [2] Das, V, Boelle, PY, Galbois, A, Guidet, B, Maury, E, Carbonell, et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med 38 (2010), 2108–2116.
3. [3] Gupta, S, Chawla, Y, Kaur, J, Saxena, R, Duseja, A, Dhiman, RK, et al. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease(MELD) score in Indian patients with cirrhosis of liver. Trop Gastroenterol 33 (2012), 129–134.
4. [4] Cassinotto, C, Lapuyade, B, Ait-Ali, A, Vergniol, J, Gaye, D, Foucher, J, et al. Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography–comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease. Radiology 269 (2013), 283–292.
5. [5] Wang, H, Feng, M, Frey, KA, Ten Haken, RK, Lawrence, TS, Cao, Y, Predictive models for regional hepatic function based on 99mTc-IDA SPECT and Local radiation dose for physiologic adaptive radiation therapy. Int J Radiat Oncol Biol Phys 86 (2013), 1000–1006.
6. [6] Verloh, N, Haimerl, M, Rennert, J, Müller-Wille, R, Nießen, C, Kirchner, G, et al. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3Tesla. Eur J Radiol 82 (2013), 1710–1715.
7. [7] Katsube, T, Okada, M, Kumano, S, Hori, M, Imaoka, I, Ishii, K, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Investig Radiol 46 (2011), 277–283.
8. [8] Tamada, T, Ito, K, Higaki, A, Yoshida, K, Kanki, A, Sato, T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol 80 (2011), 311–316.
9. [9] Le Bihan, D, Breton, E, Lallemand, D, Aubin, ML, Vignaud, J, Laval-Jeantet, M, Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168 (1988), 497–505.
10. [10] Le Bihan, D, Intravoxel incoherent motion imaging using steadystate free precession. Magn Reson Med 7 (1988), 346–351.
11. [11] Le Bihan, D, Turner, R, MacFall, JR, Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging:application to molecular diffusion imaging. Magn Reson Med 10 (1989), 324–337.
12. [12] Le Bihan, D, Turner, R, Intravoxel incoherent motion imaging using spin echoes. Magn Reson Med 19 (1991), 221–227.
13. [13] Wiesner, R, Edwards, E, Freeman, R, Harper, A, Kim, R, Kamath, P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003), 91–96.
14. [14] Luciani, A, Vignaud, A, Cavet, M, Van Nhieu, JT, Mallat, A, Ruel, L, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 249 (2008), 891–899.
15. [15] Koinuma, M, Ohashi, I, Hanafusa, K, Shibuya, H, Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22 (2005), 80–85.
16. [16] Sandrasegaran, K, Akisik, FM, Lin, C, Tahir, B, Rajan, J, Saxena, R, et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193 (2009), 1556–1560.
17. [17] Guiu, B, Cercueil, JP, Liver diffusion-weighted MR imaging: the tower of Babel?. Eur Radiol 21 (2011), 463–467.
18. [18] Guiu, B, Petit, JM, Capitan, V, Aho, S, Masson, D, Lefevre, PH, et al. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology 265 (2012), 96–103.
19. [19] Dyvorne, HA, Galea, N, Nevers, T, Fiel, M, Carpenter, D, Wong, E, et al. Diffusion- weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters—a pilot study. Radiology 266 (2013), 920–929.
20. [20] Andreou, A, Koh, DM, Collins, DJ, Blackledge, M, Wallace, T, Leach, MO, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 23 (2013), 428–434.
21. [21] Kakite, S, Dyvorne, HA, Besa, C, Cooper, N, Facciuto, M, Donnerhack, C, et al. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parametersat3.0T. J Magn Reson Imaging 41 (2015), 149–156.
22. [22] Yamada, I, Aung, W, Himeno, Y, Nakagawa, T, Shibuya, H, Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210 (1999), 617–623.
23. [23] Yoon, JH, Lee, JM, Baek, JH, Shin, CI, Kiefer, B, Han, JK, et al. Evaluation of hepatic fibro sis using intravoxel incoherent motion in diffusi on-weighte d liver MRI. J Comput Assist Tomogr 38 (2014), 110–116.
24. [24] Lewin, M, Poujol-Robert, A, Boelle, PY, Wendum, D, Lasnier, E, Viallon, M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46 (2007), 658–665.
25. [25] Bulow, R, Mensel, B, Meffert, P, Hernando, D, Evert, M, Kühn, JP, Diffusion weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol 23 (2013), 1281–1287.
26. [26] Moteki, T, Horikoshi, H, Evaluation of noncirrhotic hepatic parenchyma with and without signifiant portal vein stenosis using diffusion-weighted echo-planar MR on the basis of multiple-perfusion-components theory. Magn Reson Imaging 29 (2011), 64–73.
27. [27] Kanematsu, M, Goshima, S, Watanabe, H, Kondo, H, Kawada, H, Noda, Y, et al. Diffusion/perfusion MR imaging of the liver practice, challenges, and future. Magn Reson Med Sci 11 (2012), 151–161.
28. [28] McCuskey, RS, Ito, Y, Robertson, GR, McCuskey, MK, Perry, M, Farrell, GC, Hepatic microvascular dysfunction during evolut ion of dietarysteatohepatitis in mice. Hepatology 40 (2004), 386–393.
29. [29] Rijzewijk, LJ, van der Meer, RW, Lubberink, M, Lamb, HJ, Romijn, JA, de Roos, A, et al. Liver fat content in type 2diabetes: relationship with hepatic perfusion and substrate metabolism. Diabetes 59 (2010), 2747–2754.